1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (4957)
  2. Meeting Abstract (2007)
  3. Book Section (216)
  4. Conference Paper (122)
  5. Review (79)
  6. Editorial (48)
  7. Book Whole (28)
  8. Research Letter (15)
  9. Correspondence (8)
  10. Miscellaneous (6)
  11. Guidelines (1)
Groups
  1. Molecular Pharmacology and Chemistry Program Faculty (7487)
  2. Sloan Kettering Institute Faculty (7487)
  3. GSK Faculty (4697)
  4. Department of Medicine (2717)
  5. Surgery (2096)
  6. Center for Hematologic Malignancies (1819)

More Groups

People
  1. Murray Brennan (1059)
  2. Steven Larson (957)
  3. Peter Scardino (671)
  4. Michel Sadelain (582)
  5. Samuel Danishefsky (539)
  6. David Scheinberg (499)

More People

Years
  1. 2025 (36)
  2. 2024 (94)
  3. 2023 (122)
  4. 2022 (150)
  5. 2021 (154)
  6. 2020 (162)

More Years

Publications
  1. Journal of Nuclear Medicine (382)
  2. Blood (379)
  3. Cancer Research (340)
  4. Journal of Clinical Oncology (315)
  5. Annals of Surgical Oncology (181)
  6. International Journal of Radiation Oncology, Biology, Physics (176)

More Publications

Publishers
  1. American Association for Cancer Research (712)
  2. Elsevier Inc. (693)
  3. Nature Publishing Group (490)
  4. Springer (467)
  5. American Chemical Society (440)
  6. Elsevier Science, Inc. (405)

More Publishers

Results (7487)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinically significant advances in understanding opiate receptors
    Meeting Abstract

    Pasternak, G. W.
    Neuropsychopharmacology (2006)

    Fulltext@MSK | Save
  • A pilot study to assess the tolerability and efficacy of RAD-001 (everolimus) with gefitinib in patients with recurrent glioblastorna multiforme (GBM)
    Meeting Abstract

    Nguyen, T. D.; Lassman, A. B.; Lis, E.; Rosen, N.; Shaffer, D. R.; Scher, H. I.; Deangelis, L. M.; Abrey, L. E.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • A pilot study to assess the tolerability and efficacy of RAD-001 (everolimus) with gefitinib in patients with recurrent glioblastoma multiforme (GBM)
    Meeting Abstract

    Nguyen, T. D.; Lassman, A. B.; Lis, E.; Rosen, N.; Shaffer, D. R.; Scher, H. I.; Deangelis, L. M.; Abrey, L. E.
    Neuro-Oncology (2006)

    Fulltext@MSK | Save
  • Quantitation of stromal grade 0/3 in radical prostatectomies is a continuous marker of biochemical recurrence free survival in prostate cancer
    Meeting Abstract

    Muezzinoglu, B.; Frolov, A.; Scardino, P. T.; Wheeler, T. M.; Ayala, G.
    Modern Pathology (2006)

    Fulltext@MSK | Save
  • Quantitation of stromal grade 0/3 in radical prostatectomies is a continuous marker of biochemical recurrence free survival in prostate cancer
    Meeting Abstract

    Muezzinoglu, B.; Frolov, A.; Scardino, P. T.; Wheeler, T. M.; Ayala, G.
    Laboratory Investigation (2006)

    Fulltext@MSK | Save
  • Clinicopathological significance of multifocal prostate cancer
    Meeting Abstract

    Muezzinoglu, B.; Frolov, A.; Ohori, M.; Scardino, P. T.; Ayala, G.; Wheeler, T. M.
    Laboratory Investigation (2006)

    Fulltext@MSK | Save
  • Clinicopathological significance of multifocal prostate cancer
    Meeting Abstract

    Muezzinoglu, B.; Frolov, A.; Ohori, M.; Scardino, P. T.; Ayala, G.; Wheeler, T. M.
    Modern Pathology (2006)

    Fulltext@MSK | Save
  • Phase 2 trial of trastuzumab (T) and KOS-953 (17-AAG) in patients (pts) with Her2-positive breast cancer: Preliminary results
    Meeting Abstract

    Modi, S.; Stopeck, A.; Linden, H. M.; Sugarman, S.; Ma, W.; Solit, D.; Rosen, N.; Kersey, K.; Johnson, R. G.; Hannah, A. L.; more...
    Breast Cancer Research and Treatment (2006)

    Fulltext@MSK | Save
  • CD4+peptide epitopes from the WT1 oncoprotein stimulate CD4+and CD8+T cells that recognize and kill leukemia and solid tumor cells
    Meeting Abstract

    May, R. J.; Pinilla, J.; Korontsvit, T.; Zakhaleva, V.; Zhang, R. H.; Dao, T.; Maslak, P.; Scheinberg, D. A.
    Blood (2006)

    Fulltext@MSK | Save
  • Pilot trial of a synthetic breakpoint peptide vaccine in patients with chronic myeloid leukemia (CML) and minimal disease
    Meeting Abstract

    Maslak, P. G.; Dao, T.; Gupta, S.; Gomez, M.; Chanel, S.; Korontsvit, T.; Zakhaleva, V.; Ashraf, S.; Berman, E.; Scheinberg, D.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save